# US Diabetes Monitors Market

> US Diabetes Monitors Market Research Report By Device Type (Blood Glucose Monitors, Continuous Glucose Monitors, Smartphone Integrated Monitors, Wearable Monitors), By Technology (Strip-Based Technology, Electrochemical Technology, Enzymatic Technology, Non-Invasive Technology), By Application (Type 1 Diabetes Management, Type 2 Diabetes Management, Gestational Diabetes Management) and By End Use (Home Care, Hospital Care, Diagnostic Laboratories) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.74%
- **2024:** $ 2,915.5 Million
- **2025:** $ 3,082.85 Million
- **2035:** $ 5,387.06 Million
- **Key Players:** Abbott (US), Roche (CH), Dexcom (US), Medtronic (US), Bayer (DE), Ascensia Diabetes Care (DE), Terumo (JP), GlucoRx (GB), Insulet (US)

**Report ID:** MRFR/MED/13123-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-diabetes-monitors-market-14650

---

## Market Summary

## **US Diabetes Monitors Market Overview**

As per MRFR analysis, the US Diabetes Monitors Market Size was estimated at 2.76 (USD Billion) in 2023. The US Diabetes Monitors Market Industry is expected to grow from 3(USD Billion) in 2024 to 6 (USD Billion) by 2035. The US Diabetes Monitors Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).

### **Key US Diabetes Monitors Market Trends Highlighted**

The US Diabetes Monitors Market has seen several important trends that reflect both advancements in technology and changes in consumer behavior. One key market driver is the increasing prevalence of diabetes in the United States, with statistics indicating that millions of Americans are living with this chronic condition. This growth has prompted a higher demand for innovative and effective monitoring solutions, particularly as healthcare providers emphasize better management of diabetes.

The rise in awareness among patients regarding their condition is leading to greater adoption of continuous glucose monitors (CGMs) and other advanced monitoring systems that promote real-time tracking of blood sugar levels.

Opportunities to be explored in the US market include enhancements in digital health technology, such as mobile apps that can integrate with glucose monitors for improved data analysis. This intersection of technology and health provides a fertile ground for development, allowing for tailored healthcare solutions that align more closely with individual patient needs. Additionally, the shift towards value-based care models in the US healthcare system encourages the creation of cost-effective monitoring devices that not only enhance patient engagement but also provide tangible health outcomes.

Recent trends indicate a growing preference for non-invasive monitoring technologies. Patients show interest in less painful methods compared to traditional finger-prick tests, demonstrating a demand for user-friendly and accessible solutions. Furthermore, the COVID-19 pandemic has accelerated the adoption of telemedicine, which has made remote monitoring a viable option for diabetes management. The integration of diabetes monitors with telehealth platforms could offer seamless patient care and regular monitoring, shaping the future landscape of diabetes management in the US. Thus, the market is poised for significant growth that aligns with technological advancements and evolving consumer expectations.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Diabetes Monitors Market Drivers**

### **Increasing Prevalence of Diabetes**

The rising prevalence of diabetes in the United States is a significant driver for the US Diabetes Monitors Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 37.3 million Americans, or 11.3% of the total population, are living with diabetes as of 2022. This staggering statistic highlights a growing population that requires effective monitoring solutions. With the continuous rise in diabetes cases, largely attributed to increasing obesity rates, sedentary lifestyles, and unhealthy eating habits, there is an ever-accelerating demand for diabetes monitoring devices.

Furthermore, the National Institutes of Health documents that diabetes is expected to affect an additional 7.2 million people by 2030, ultimately expanding the market for diabetes monitors as patients seek effective management of their condition. Major organizations, such as Abbott Laboratories and Dexcom, are innovating technology to meet the needs of this expanding demographic, consequently impacting market growth.

### **Technological Advancements in Monitoring Devices**

Advancements in technology within the diabetes monitoring sector significantly influence the US Diabetes Monitors Market Industry. Continuous innovations, such as the development of continuous glucose monitoring systems and smartphone integration, have improved the accuracy and convenience of blood sugar monitoring. The American Diabetes Association states that the use of technology, including automated insulin delivery systems, has been linked to better metabolic health in diabetes patients.

As consumers exhibit a preference for user-friendly devices, industry leaders like Medtronic and FreeStyle are committed to Research and Development (R&D) to enhance product offerings. This drive for improved technology propels the diabetes monitoring market forward while fostering positive changes in patient management.

### **Government Initiatives and Support**

In the United States, government initiatives aimed at combating diabetes prevalence cause a ripple effect in the US Diabetes Monitors Market Industry. Policies that promote diabetes education, awareness campaigns, and subsidies for diabetes management devices contribute to an environment conducive to growth. The U.S. Department of Health and Human Services launched the National Diabetes Prevention Program, targeting a 50% reduction in diabetes cases by 2030. This initiative fosters a need for more diabetes monitoring solutions and encourages consumer adoption.

Organizations like the American Diabetes Association actively support these initiatives, facilitating the development and deployment of new products to meet the growing demand in the marketplace.

## **US Diabetes Monitors Market Segment Insights**

### **Diabetes Monitors Market Device Type Insights**

The US Diabetes Monitors Market is diversifying, particularly in the Device Type segment, which consists of various innovative monitoring solutions. Blood Glucose Monitors hold a significant share of the market due to their widespread use among diabetes patients for routine glucose level checks. These devices have evolved over the years, integrating features like Bluetooth connectivity and touch screen interfaces, which enhance user experience and data management. Continuous Glucose Monitors (CGMs) have gained traction owing to their ability to provide real-time glucose readings, making them essential for patients who require constant monitoring and aiming to achieve tighter glucose control.

This device type also reduces the necessity for frequent fingerstick tests, greatly improving the quality of life for individuals with diabetes.

Additionally, Smartphone Integrated Monitors are emerging as a game-changer within the segment, allowing users to seamlessly track their glucose levels via mobile applications. This integration not only offers convenience but also facilitates data sharing with healthcare providers, enhancing collaborative care strategies. Wearable Monitors, another innovative category, have seen increased interest as the demand for non-invasive and continuous health monitoring rises among the tech-savvy population. These devices often come packaged with advanced features such as health-tracking ecosystems, which provide comprehensive insights into the user's overall health status.

The growing prevalence of diabetes in the US, which affects an estimated 34.2 million people, drives the demand for these devices, propelling market growth. With technological advancements and increased adoption of digital health, the Device Type segment in the US Diabetes Monitors Market is set to evolve and thrive, addressing the diverse needs and challenges faced by diabetes patients in their daily lives. Consumer preference for personalized healthcare solutions presents ample opportunities for innovation and market expansion, further solidifying the importance of each category within the US Diabetes Monitors Market landscape, ultimately supporting improved patient outcomes and management.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Diabetes Monitors Market Technology Insights**

The Technology segment of the US Diabetes Monitors Market has experienced considerable growth and innovation in recent years as it meets the evolving needs of diabetic patients. Strip-Based Technology remains a key player, providing users with a simple and efficient method for blood glucose monitoring, which is crucial for daily management and control of diabetes. Electrochemical Technology is gaining traction due to its high accuracy levels and minimal blood sample requirements, making it a preferred choice among healthcare professionals and patients alike.

Enzymatic Technology is valued for its ability to facilitate specific glucose detection, enhancing the reliability of readings and allowing users to achieve better management of their condition. Non-Invasive Technology is emerging as a promising area, drawing significant interest from consumers due to its potential to offer pain-free glucose monitoring solutions, likely transforming diabetes care and appealing to patients who prefer less invasive methods. The ongoing advancements in these areas contribute to a diverse landscape within the US Diabetes Monitors Market, driven by technological innovations and increasing demand for user-friendly, efficient monitoring solutions.

This robust segment is positioned well for continued growth as it addresses the needs of an aging population and the rise in diabetes prevalence across the country.

### **Diabetes Monitors Market Application Insights**

The Application segment of the US Diabetes Monitors Market plays a critical role in addressing the diverse needs of diabetes management. With a growing prevalence of diabetes in the United States, the need for effective monitoring solutions has become paramount. Type 1 Diabetes Management primarily focuses on advanced monitoring technologies that cater to the specific requirements of individuals who rely on insulin therapy, helping them maintain optimal blood glucose levels. Alternatively, Type 2 Diabetes Management has witnessed a surge in demand due to lifestyle-related factors, necessitating innovative tools that promote self-management and preventive care.

Gestational Diabetes Management stands out for its importance in providing specialized resources for expectant mothers, ensuring both maternal and fetal health. Collectively, these applications contribute significantly to the US Diabetes Monitors Market, driven by increasing awareness, technological advancements, and the essential role of regular monitoring in reducing complications associated with diabetes. As the market continues to evolve, it is essential to recognize the value of tailored monitoring solutions that cater to diverse patient needs.

### **Diabetes Monitors Market End Use Insights**

The End Use segment of the US Diabetes Monitors Market highlights the importance of tailored solutions for diverse healthcare settings. Home Care has seen substantial growth, driven by increasing patient preferences for self-monitoring and a shift towards personalized diabetes management, allowing individuals to actively manage their health in a familiar environment. Hospital Care plays a crucial role by providing advanced monitoring technologies that enable healthcare professionals to track patient glucose levels with precision, ensuring timely interventions. Diagnostic Laboratories are integral to this ecosystem, as they facilitate comprehensive testing and analysis, which is essential for accurate diagnoses and treatment planning.

The adoption of diabetes monitoring tools is influenced by rising diabetes prevalence in the US, with around 37 million Americans affected. The market is further propelled by technological advancements, such as continuous glucose monitoring devices, which are instrumental in enhancing patient outcomes. However, challenges like the need for extensive training and accuracy in readings remain. Overall, each area within this segment contributes significantly to improved diabetes management, demonstrating the critical need for innovative solutions and patient-focused care in the healthcare landscape.

## **US Diabetes Monitors Market Key Players and Competitive Insights**

The US Diabetes Monitors Market is experiencing significant growth due to the increasing prevalence of diabetes and the rising awareness of glucose monitoring technologies. Factors contributing to the competitive landscape include advancements in technologies such as continuous glucose monitoring systems, as well as the emergence of innovative products aimed at improving patient outcomes. As various players vie for market share, differentiation through product quality, reliability, and user-friendly features becomes paramount.

The dynamic nature of this market ensures that companies are continuously innovating and strategizing to enhance their competitive positions, which intensifies rivalry among established firms while providing growth opportunities for emerging entrants.

Acon Laboratories has established itself as a formidable player within the US Diabetes Monitors Market, primarily due to its focus on the development of advanced monitoring devices that cater to the needs of diabetic patients. With a strong emphasis on quality and precision, Acon Laboratories provides accurate blood glucose monitoring solutions that are designed to simplify the lives of patients and healthcare professionals alike. Their product offerings not only highlight technological innovation but also prioritize user satisfaction, making them a trusted name in glucose monitoring.

The company's commitment to extensive research and development ensures that they remain competitive, capitalizing on their strengths in product reliability and customer service to maintain a solid presence in the market.

Terumo Corporation is another important contender in the US Diabetes Monitors Market, known for its diverse range of medical devices and products aimed at improving diabetes management. The company has made significant strides in this market with its advanced monitoring solutions, which are characterized by their accuracy and ease of use. Terumo Corporation's strategic focus includes maintaining strong relationships with healthcare providers and engaging in continuous improvement of their product lines. The company has made notable investments in recent years, including mergers and acquisitions that have bolstered their research capabilities and expanded their presence in the US market.

Their dedication to innovation in diabetes care, alongside a commitment to customer support and partnerships, positions Terumo Corporation favorably for future growth within this evolving landscape.

### **Key Companies in the US Diabetes Monitors Market Include**

- Acon Laboratories
- Terumo Corporation
- **[Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products.html)**
- Dexcom
- Abbott Laboratories
- Ascensia Diabetes Care
- GlucoMe
- Siemens Healthineers
- Roche
- Trividia Health
- Omnicare
- Johnson and Johnson
- LifeScan
- Bayer
- Handheld Products

## **US Diabetes Monitors Market Industry Developments**

The US Diabetes Monitors Market has experienced significant advancements recently, particularly in the area of continuous glucose monitoring (CGM) technology and user-friendly devices. Companies like Dexcom and Medtronic have introduced innovative CGM systems that feature enhanced accuracy and real-time data sharing capabilities, catering to the rising number of diabetes patients in the country. In September 2023, Abbott Laboratories launched an updated version of its FreeStyle Libre sensor, which promises improved performance and convenience. Furthermore, in October 2022, Terumo Corporation announced its acquisition of the US-based company, which expands its reach into the diabetes management sector.

The market continues to grow, driven by increasing diabetes prevalence and the demand for advanced monitoring solutions. Investment in Research and Development by major players such as Johnson and Johnson, Siemens Healthineers, and Roche reflects a commitment to enhancing patient outcomes and preventative care. In recent years, key regulatory approvals have also facilitated faster market entry for new devices, solidifying the US as a vital hub for diabetes technology innovations. As a result, the overall market valuation is witnessing robust growth, illustrating the critical importance of effective diabetes management in public health strategies.

## **US Diabetes Monitors Market Segmentation Insights**

### **Diabetes Monitors Market Device Type Outlook**

- Blood Glucose Monitors
- Continuous Glucose Monitors
- Smartphone Integrated Monitors
- Wearable Monitors

### **Diabetes Monitors Market Technology Outlook**

- Strip-Based Technology
- Electrochemical Technology
- Enzymatic Technology
- Non-Invasive Technology

### **Diabetes Monitors Market Application Outlook**

- Type 1 Diabetes Management
- Type 2 Diabetes Management
- Gestational Diabetes Management

### **Diabetes Monitors Market End Use Outlook**

- Home Care
- Hospital Care
- Diagnostic Laboratories

## Market Drivers

### Growing Prevalence of Diabetes

The increasing prevalence of diabetes in the US is a primary driver for the diabetes monitors market. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 million Americans, or 10.5% of the population, have diabetes. This rising number necessitates effective monitoring solutions, leading to heightened demand for diabetes monitors. As the population ages and lifestyle-related factors contribute to the disease's growth, the diabetes monitors market is expected to expand significantly. The need for continuous glucose monitoring (CGM) systems and other advanced monitoring devices is likely to increase, as patients and healthcare providers seek to manage diabetes more effectively. This trend indicates a robust market potential, as innovations in monitoring technology continue to emerge, catering to the needs of a growing diabetic population.

### Aging Population and Lifestyle Changes

The aging population in the US, coupled with lifestyle changes, is a critical driver of the diabetes monitors market. As individuals age, the risk of developing diabetes increases, leading to a higher demand for monitoring solutions. The US Census Bureau projects that by 2030, approximately 20% of the population will be 65 years or older, which may further escalate the prevalence of diabetes. Additionally, lifestyle changes, such as sedentary behavior and poor dietary habits, contribute to the rising incidence of diabetes. This demographic shift indicates a growing market for diabetes monitors, as older adults often require more frequent monitoring to manage their health effectively. The diabetes monitors market is likely to expand in response to these trends, as manufacturers develop products tailored to the needs of an aging population.

### Increasing Health Awareness and Education

The rising health awareness and education regarding diabetes management are significant drivers of the diabetes monitors market. Public health campaigns and educational programs have been instrumental in informing individuals about the importance of regular monitoring and effective diabetes management. As more people become aware of the risks associated with uncontrolled diabetes, the demand for monitoring devices is likely to increase. This trend is further supported by healthcare professionals advocating for proactive management strategies. The diabetes monitors market stands to benefit from this heightened awareness, as patients seek reliable tools to help them manage their condition effectively. The emphasis on education and self-management is expected to foster a culture of health, ultimately leading to increased sales of diabetes monitoring devices.

### Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies play a crucial role in driving the diabetes monitors market. The US Food and Drug Administration (FDA) has streamlined the approval process for new diabetes monitoring devices, encouraging innovation and market entry. Additionally, many insurance providers are increasingly covering the costs associated with diabetes monitors, making them more accessible to patients. This financial support is vital, as it alleviates the burden of out-of-pocket expenses for individuals managing diabetes. As reimbursement policies evolve to include advanced monitoring technologies, the diabetes monitors market is likely to witness accelerated growth. The combination of regulatory facilitation and financial backing creates a conducive environment for manufacturers to introduce new products, ultimately benefiting patients and healthcare systems alike.

### Technological Innovations in Monitoring Devices

Technological innovations are transforming the diabetes monitors market, enhancing the accuracy and usability of monitoring devices. Recent advancements include the development of non-invasive glucose monitoring technologies, which may eliminate the need for fingerstick blood tests. These innovations are appealing to patients who prefer less invasive methods for managing their condition. Furthermore, the integration of mobile applications and cloud-based data management systems allows for real-time monitoring and data sharing with healthcare providers. This connectivity is expected to improve patient outcomes and adherence to treatment plans. As technology continues to evolve, the diabetes monitors market is poised for growth, with new products that offer enhanced features and improved user experiences. The ongoing research and development efforts in this sector suggest a promising future for both manufacturers and consumers.

## Future Outlook

The [Diabetes Monitors Market](https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781) is projected to grow at a 5.74% CAGR from 2025 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising health awareness.

**New opportunities:**

- Development of integrated telehealth platforms for remote monitoring. Expansion of subscription-based services for continuous glucose monitoring. Investment in AI-driven analytics for personalized diabetes management.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased consumer demand.

## Segment Insights

### By Device Type: Blood Glucose Monitors (Largest) vs. Continuous Glucose Monitors (Fastest-Growing)

The US diabetes monitors market exhibits a diverse range of device types, with Blood Glucose Monitors holding the largest share. These traditional devices provide essential functionality for daily monitoring and remain a staple among users. In comparison, Continuous Glucose Monitors have emerged as a vital segment, leveraging advanced technology to offer real-time tracking and data insights that enhance diabetes management.

Growth trends in the segment are significantly influenced by technological advancements and increasing consumer awareness. Continuous Glucose Monitors are rapidly gaining traction due to their convenience and accuracy, appealing to a tech-savvy patient base. Furthermore, the integration of smart features in devices, such as connectivity with smartphones, is propelling the adoption of innovative monitoring solutions throughout the US diabetes monitors market.

Blood Glucose Monitors (Dominant) vs. Continuous Glucose Monitors (Emerging)

Blood Glucose Monitors have long been the cornerstone of diabetes management, offering users straightforward functionality and affordability. These devices typically require users to prick their finger to obtain blood samples for testing, making them accessible and familiar. On the other hand, Continuous Glucose Monitors represent an emerging category that is transforming how users manage their condition. By providing real-time glucose readings and historical data, these devices allow for more informed decision-making regarding insulin administration and diet. The ongoing innovation in CGM technology, including enhanced accuracy and longer wear times, is positioning them as a critical tool for diabetes care in the evolving US diabetes monitors market.

### By Technology: Electrochemical Technology (Largest) vs. Non-Invasive Technology (Fastest-Growing)

Among the various technologies in the US diabetes monitors market, Electrochemical Technology holds the largest market share, dominating the landscape due to its established efficacy and reliability. Strip-Based Technology and Enzymatic Technology follow, with more niche applications, while Non-Invasive Technology is gaining traction among consumers seeking comfort and convenience in glucose monitoring. The combined dynamics of these technologies shape a diverse market with varying consumer preferences based on usability and accuracy.

Looking ahead, Non-Invasive Technology is poised to see the fastest growth driven by increasing consumer demand for painless monitoring solutions and advances in sensor technology. As patients seek more innovative and comfortable options, manufacturers are focusing on enhancing the performance and accuracy of non-invasive devices. This shift reflects broader trends in health monitoring, positioning Non-Invasive Technology as a key player in the future of diabetes management.

Technology: Electrochemical (Dominant) vs. Non-Invasive (Emerging)

Electrochemical Technology is currently the dominant force in the US diabetes monitors market, offering highly accurate and reliable readings which have led to widespread adoption. Devices utilizing this technology are often favored by patients who prioritize precision in monitoring their blood glucose levels. In contrast, Non-Invasive Technology represents an emerging segment that appeals to a growing consumer base looking for innovative solutions that eliminate the discomfort associated with traditional monitoring methods. While it is still developing, Non-Invasive Technology is becoming increasingly viable, as advancements in wearable sensors and real-time monitoring solutions gain popularity. Therefore, a dual focus on accuracy through Electrochemical Technology and comfort via Non-Invasive options highlights the evolving landscape of diabetes management.

### By Application: Type 2 Diabetes Management (Largest) vs. Gestational Diabetes Management (Fastest-Growing)

The market share distribution within the application segment of the US diabetes monitors market showcases Type 2 Diabetes Management as the largest segment, significantly dominating the landscape due to the higher prevalence of this type of diabetes among the population. In contrast, Type 1 Diabetes Management holds a noteworthy share but is eclipsed by Type 2, while Gestational Diabetes Management is emerging as a critical focus area owing to increased awareness and the rising number of pregnancies complicated by diabetes in the US.  

Growth trends in the application segment reveal a marked increase in the adoption of diabetes monitoring technologies across all types. Type 2 Diabetes Management experiences continuous growth driven by the increasing incidence of obesity and the focus on preventive healthcare. Meanwhile, the demand for Gestational Diabetes Management is rapidly advancing, fueled by public health initiatives emphasizing screening and management for expectant mothers to ensure maternal and fetal well-being, thereby positioning it as the fastest-growing application.

Type 2 Diabetes Management (Dominant) vs. Gestational Diabetes Management (Emerging)

Type 2 Diabetes Management is recognized as the dominant application segment in the US diabetes monitors market due to its extensive user base and critical role in chronic illness management. It typically features comprehensive monitoring tools tailored for long-term health management strategies. In contrast, Gestational Diabetes Management is emerging as a vital segment, addressing the unique needs of expectant mothers diagnosed with diabetes. This application is characterized by tailored monitoring solutions that focus on both maternal health and fetal development, driven by growing guidelines encouraging regular testing during pregnancy. As healthcare providers increasingly recognize the significance of managing diabetes in pregnancy, the Gestational Diabetes segment is expected to see robust growth, complemented by patient education and technological advancements.

### By End Use: Home Care (Largest) vs. Hospital Care (Fastest-Growing)

In the US diabetes monitors market, the distribution of end use segments highlights the dominance of Home Care, accounting for a significant share due to the rising preference for at-home management of diabetes. Hospital Care follows, reflecting the need for advanced monitoring technologies in clinical settings, while Diagnostic Laboratories play a smaller role in the overall market share, focusing on comprehensive testing and diagnostics.

Growth trends within the end use segments indicate a marked increase in the adoption of diabetes monitors for Home Care, driven by the growing awareness of diabetes management. Meanwhile, Hospital Care is the fastest-growing segment, propelled by innovations in monitoring technologies and increasing patient admissions, leading to enhanced demand for accurate diabetes monitoring in clinical environments.

Home Care (Dominant) vs. Hospital Care (Emerging)

Home Care remains the dominant segment in the US diabetes monitors market, as individuals increasingly seek convenient monitoring solutions that empower them to manage their health more effectively. This shift is facilitated by technological advancements in portable and user-friendly devices. In contrast, Hospital Care is emerging as a significant segment due to the rising importance of precision in diabetes management within healthcare facilities. With advancements in telemetry and connected health technologies, hospitals are adopting more sophisticated monitoring systems that promise improved patient outcomes, showcasing a robust growth trajectory fueled by technological progress and the rising prevalence of diabetes.

## Competitive Benchmarking

The diabetes monitors market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for effective diabetes management solutions. Key players such as Abbott (US), Dexcom (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Abbott (US) focuses on innovation, particularly with its continuous glucose monitoring (CGM) systems, which have gained traction due to their user-friendly design and accuracy. Dexcom (US) emphasizes partnerships with healthcare providers to expand its reach, while Medtronic (US) is investing heavily in digital transformation to integrate its devices with mobile health applications, thereby enhancing patient engagement and data accessibility.The market structure appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to improve efficiency and reduce costs. This collective approach not only enhances operational capabilities but also fosters a competitive environment where agility and responsiveness to market demands are crucial.
In October Abbott (US) announced the launch of its latest CGM system, which features advanced algorithms for improved glucose prediction. This strategic move is significant as it positions Abbott to capture a larger share of the growing demand for real-time glucose monitoring, particularly among tech-savvy consumers seeking more accurate and reliable diabetes management tools. The introduction of this system is likely to enhance patient outcomes and solidify Abbott's reputation as a leader in diabetes technology.
In September Dexcom (US) expanded its partnership with a major telehealth provider, enabling remote monitoring capabilities for patients. This collaboration is pivotal as it aligns with the increasing trend towards telemedicine, allowing for more comprehensive diabetes management solutions. By integrating its technology with telehealth services, Dexcom is not only enhancing patient access to care but also positioning itself as a key player in the evolving healthcare landscape.
In August Medtronic (US) unveiled a new software platform designed to integrate data from various diabetes management devices. This initiative is crucial as it reflects the growing importance of data interoperability in healthcare. By facilitating seamless data exchange, Medtronic aims to enhance the user experience and provide healthcare professionals with comprehensive insights into patient health, thereby improving treatment outcomes.
As of November the competitive trends in the diabetes monitors market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological innovation, enhanced patient engagement, and supply chain reliability. This shift suggests that companies that prioritize R&D and strategic partnerships will be better positioned to thrive in the future.

## Recent News & Developments

The US Diabetes Monitors Market has experienced significant advancements recently, particularly in the area of continuous glucose monitoring (CGM) technology and user-friendly devices. Companies like Dexcom and Medtronic have introduced innovative CGM systems that feature enhanced accuracy and real-time data sharing capabilities, catering to the rising number of diabetes patients in the country. In September 2023, Abbott Laboratories launched an updated version of its FreeStyle Libre sensor, which promises improved performance and convenience. Furthermore, in October 2022, Terumo Corporation announced its acquisition of the US-based company, which expands its reach into the diabetes management sector.

The market continues to grow, driven by increasing diabetes prevalence and the demand for advanced monitoring solutions. Investment in Research and Development by major players such as Johnson and Johnson, Siemens Healthineers, and Roche reflects a commitment to enhancing patient outcomes and preventative care. In recent years, key regulatory approvals have also facilitated faster market entry for new devices, solidifying the US as a vital hub for diabetes technology innovations. As a result, the overall market valuation is witnessing robust growth, illustrating the critical importance of effective diabetes management in public health strategies.

## Report Scope

| MARKET SIZE 2024 | 2915.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 3082.85(USD Million) |
| MARKET SIZE 2035 | 5387.06(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.74% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott (US), Roche (CH), Dexcom (US), Medtronic (US), Bayer (DE), Ascensia Diabetes Care (DE), Terumo (JP), GlucoRx (GB), Insulet (US) |
| Segments Covered | Device Type, Technology, Application, End Use |
| Key Market Opportunities | Integration of advanced digital health technologies enhances user engagement in the diabetes monitors market. |
| Key Market Dynamics | Technological advancements drive innovation in diabetes monitors, enhancing patient management and regulatory compliance in the US. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the overall market valuation of the US diabetes monitors market in 2024?**
A: The overall market valuation was $2915.5 Million in 2024.

**Q: What is the projected market valuation for the US diabetes monitors market by 2035?**
A: The projected valuation for 2035 is $5387.06 Million.

**Q: What is the expected CAGR for the US diabetes monitors market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during the forecast period is 5.74%.

**Q: Which company is a key player in the US diabetes monitors market?**
A: Key players include Abbott (US), Roche (CH), and Dexcom (US), among others.

**Q: What were the revenue figures for Blood Glucose Monitors in 2024?**
A: The revenue for Blood Glucose Monitors was between $1200.0 Million and $2200.0 Million in 2024.

**Q: How much is the market for Continuous Glucose Monitors expected to grow by 2035?**
A: The market for Continuous Glucose Monitors is projected to grow from $1000.0 Million to $1800.0 Million by 2035.

**Q: What is the revenue range for Type 2 Diabetes Management in 2024?**
A: The revenue range for Type 2 Diabetes Management was between $1800.0 Million and $3200.0 Million in 2024.

**Q: What segment had the highest revenue in the US diabetes monitors market in 2024?**
A: The segment with the highest revenue was Type 2 Diabetes Management, with figures reaching up to $3200.0 Million.

**Q: What is the projected revenue for Wearable Monitors by 2035?**
A: The projected revenue for Wearable Monitors is expected to reach between $215.5 Million and $487.06 Million by 2035.

**Q: What technology segment is anticipated to see significant growth in the US diabetes monitors market?**
A: The Strip-Based Technology segment is anticipated to grow from $1000.0 Million to $1800.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-diabetes-monitors-market-14650*